PSTX NASDAQ
Poseida Therapeutics, Inc.
1W: -1.0%
1M: +1.5%
3M: +269.6%
1Y: +194.1%
3Y: +38.5%
$9.50
Last traded 2025-01-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$151M
Revenue
+204.0% YoY
$-59M
Net Income
+55.3% YoY
$-17M
Free Cash Flow
+73.3% YoY
100.0%
Gross Margin
27.5%
Op. Margin
28.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-56.3%
ROA-19.9%
ROIC81.1%
Valuation
P/E-6.9
P/B8.3
EV/EBITDA-2.9
Leverage
Debt/Equity0.95
Current Ratio3.20
Interest Cov.-5.7x
Quality Scores
Piotroski F5/9
Altman Z-1.55
Beneish M2.10